Skip to search formSkip to main contentSkip to account menu

Roniciclib

An orally bioavailable cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. Roniciclib selectively binds to and inhibits… 
National Institutes of Health

Search for papers about Roniciclib

Search papers